Aliskiren (Tekturna) for Hypertension
Aliskiren (ah LIS ker in; Tekturna - Novartis), the first direct renin inhibitor, has been approved by the FDA for treatment of hypertension. It is indicated for oral use either as monotherapy or in combination with other antihypertensive agents....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Aliskiren (Tekturna) for Hypertension
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1258
Article Code: 1258a
Date: April 9, 2007
Volume: 49
Pages: 29-31
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1258
Article Code: 1258a
Date: April 9, 2007
Volume: 49
Pages: 29-31
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)